Isarna Presents First Interim Phase I Data for ISTH0036 in Advanced Glaucoma at ARVO 2016 Annual Conference -- Preliminary Data Shows That ISTH0036 was Safe and Well Tolerated at Therapeutic Dose Levels -Munich, Germany, - Glaucoma - Document - PDFSEARCH.IO

First Page	Meta Content
	Isarna Presents First Interim Phase I Data for ISTH0036 in Advanced Glaucoma at ARVO 2016 Annual Conference -- Preliminary Data Shows That ISTH0036 was Safe and Well Tolerated at Therapeutic Dose Levels -Munich, Germany, Add to Reading List Document Date: 2016-05-04 04:50:51 Open Document File Size: 261,53 KB Share Result on Facebook

Isarna Presents First Interim Phase I Data for ISTH0036 in Advanced Glaucoma at ARVO 2016 Annual Conference -- Preliminary Data Shows That ISTH0036 was Safe and Well Tolerated at Therapeutic Dose Levels -Munich, Germany,Add to Reading List